Ultrasound Market by Technology (2D,3D,Doppler,CEU,HIFU, ESWL), Display (Colour, B/W), Portability (Trolly, Compact,POC), Component (Linear, Phased array, Workstation), Application (OB/GYN, Cardiology, Ortho), End User (Hospitals) Global Forecasts to 2030
The global ultrasound market is projected to reach USD 13.87 billion by 2030 from USD 9.32 billion in 2024, growing at a CAGR of 6.8% during the forecast period. The growth of the ultrasound market is driven by various key factors, including increasing prevalence rates of chronic diseases, such as cardiovascular conditions, cancer, and musculoskeletal disorders. These require sophisticated diagnostic equipment. Increasing demand for early diagnosis and non-invasive options also fuels adoption of the ultrasound technology. Advances in ultrasound itself, including AI integration, 3D/4D imaging, and portable equipment, make it more accessible and versatile in the clinical practice.
“Diagnostic Ultrasound to register largest market share in 2023”
Diagnostic ultrasound accounts for the largest share of the ultrasound market because it is capable of providing real-time, non-invasive imaging for a wide range of medical conditions. Its broad usage in obstetrics, cardiology, musculoskeletal imaging, and emergency care is contributing to its dominance. With this technology, it boasts such high accuracy, very low cost, and ionizing radiation-free; clinicians often turn to this for routine diagnostics. Improved ultrasound technology-3D/4D imaging, for instance, and AI-based tools have improved it so much that the use has remained on the growth track.
“Hospitals segment held the largest share of ultrasound equipment market in 2023, by End-user.”
Hospitals have the largest market share in this ultrasound industry due to its high volume of patients and diversified departments, along with the requirements of advanced imaging diagnostics within a wide spectrum of specializations. Obsterics, cardiology, emergency care, and musculoskeletal imaging are key applications within the hospital setup that have integrated ultrasound technology. The increased cases of chronic diseases and hospital emphasis on earlier diagnosis and treatment create high demand for ultrasound systems. More importantly, the advanced functionalities of ultrasound, such as real-time imaging, non-invasiveness, and increased accuracy, make it of more importance to hospitals, thereby becoming their main consumers of ultrasound technology.
'Asia Pacific to register highest growth rate in the market during the forecast period.'
The Asia-Pacific region is reporting the highest growth rate in the ultrasound market, with factors such as an increasingly prevalent chronic disease population, an aged population, and a widening healthcare infrastructure base. Growth in demand for early and accurate diagnoses coupled with the affordability of ultrasound and its non-invasive nature has further increased adoption across the region. Additionally, growing government efforts to expand the healthcare market, increasing investments in health, diagnostic center expansions, and increase in hospital numbers are leading the rapid growth of this market in the Asia-Pacific region. Technology advancement and the greater availability of portable ultrasound equipment facilitate wider accessibility and adoption in Asia-Pacific.
A number of drivers were responsible for the upswing, including:
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
The ultrasound equipment market has been segmented based on technology, display, component, portability, application, end-user, and region. Key factors for the growth of the market include driving forces, restraints, opportunities, and challenges among the stakeholders. The study also looks into the competition of the leading players within the market. The further division of the market can be seen in micro-markets to gain insight into the growth trends, prospects, and contributions to the overall market. It highlights future revenue growth prospects for various market segments across five major regions.
Key Benefits of Buying the Report:
The report would be useful for new market entrants in the ultrasound market as it gives detailed information about the market. This helps get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. This report segments the market precisely both by end-users and by regions for the purpose of attaining focused insights in the specific market segments. Additionally, it draws out the major trends, challenges, growth drivers, and opportunities to support the strategic decision-making process through adequate analysis.
The report provides the insights on the following pointers:
Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the ultrasound market. The rise of point-of-care diagnostics and expanding healthcare infrastructure further boosts market growth. Additionally, favorable reimbursement policies and the need for early detection support ultrasound adoption.
Product Development/Innovation: The report includes emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for ultrasound market.
Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the ultrasound market.
Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the ultrasound market.
Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), among others.
“Diagnostic Ultrasound to register largest market share in 2023”
Diagnostic ultrasound accounts for the largest share of the ultrasound market because it is capable of providing real-time, non-invasive imaging for a wide range of medical conditions. Its broad usage in obstetrics, cardiology, musculoskeletal imaging, and emergency care is contributing to its dominance. With this technology, it boasts such high accuracy, very low cost, and ionizing radiation-free; clinicians often turn to this for routine diagnostics. Improved ultrasound technology-3D/4D imaging, for instance, and AI-based tools have improved it so much that the use has remained on the growth track.
“Hospitals segment held the largest share of ultrasound equipment market in 2023, by End-user.”
Hospitals have the largest market share in this ultrasound industry due to its high volume of patients and diversified departments, along with the requirements of advanced imaging diagnostics within a wide spectrum of specializations. Obsterics, cardiology, emergency care, and musculoskeletal imaging are key applications within the hospital setup that have integrated ultrasound technology. The increased cases of chronic diseases and hospital emphasis on earlier diagnosis and treatment create high demand for ultrasound systems. More importantly, the advanced functionalities of ultrasound, such as real-time imaging, non-invasiveness, and increased accuracy, make it of more importance to hospitals, thereby becoming their main consumers of ultrasound technology.
'Asia Pacific to register highest growth rate in the market during the forecast period.'
The Asia-Pacific region is reporting the highest growth rate in the ultrasound market, with factors such as an increasingly prevalent chronic disease population, an aged population, and a widening healthcare infrastructure base. Growth in demand for early and accurate diagnoses coupled with the affordability of ultrasound and its non-invasive nature has further increased adoption across the region. Additionally, growing government efforts to expand the healthcare market, increasing investments in health, diagnostic center expansions, and increase in hospital numbers are leading the rapid growth of this market in the Asia-Pacific region. Technology advancement and the greater availability of portable ultrasound equipment facilitate wider accessibility and adoption in Asia-Pacific.
A number of drivers were responsible for the upswing, including:
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 40%, Tier 30%, and Tier 3 30%
- By Designation: C-level-- 55%, Director-level–27%, and Others–18%
- By Region: North America–35%, Europe-32%, Asia Pacific–25%, Latin America-6% , Middle East & Africa-2%
Research Coverage
The ultrasound equipment market has been segmented based on technology, display, component, portability, application, end-user, and region. Key factors for the growth of the market include driving forces, restraints, opportunities, and challenges among the stakeholders. The study also looks into the competition of the leading players within the market. The further division of the market can be seen in micro-markets to gain insight into the growth trends, prospects, and contributions to the overall market. It highlights future revenue growth prospects for various market segments across five major regions.
Key Benefits of Buying the Report:
The report would be useful for new market entrants in the ultrasound market as it gives detailed information about the market. This helps get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. This report segments the market precisely both by end-users and by regions for the purpose of attaining focused insights in the specific market segments. Additionally, it draws out the major trends, challenges, growth drivers, and opportunities to support the strategic decision-making process through adequate analysis.
The report provides the insights on the following pointers:
Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the ultrasound market. The rise of point-of-care diagnostics and expanding healthcare infrastructure further boosts market growth. Additionally, favorable reimbursement policies and the need for early detection support ultrasound adoption.
Product Development/Innovation: The report includes emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for ultrasound market.
Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the ultrasound market.
Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the ultrasound market.
Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), among others.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Customer-based market estimation
2.2.1.3 Approach 3: Top-down approach
2.2.1.4 Approach 4: Primary interviews
2.3 DATA TRIANGULATION & MARKET BREAKDOWN
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ULTRASOUND MARKET OVERVIEW
4.2 ULTRASOUND MARKET, BY REGION, 2022–2030
4.3 EUROPE: ULTRASOUND MARKET, BY REGION AND END USER, 2023
4.4 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Rising patient preference for minimally invasive surgeries
5.2.1.3 Rising technological advancements in ultrasound devices
5.2.1.4 Growing public and private investments, funding, and grants
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursements
5.2.2.2 High operating costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing applications of therapeutic ultrasound
5.2.3.2 Growth in emerging markets
5.2.3.3 Development of POC ultrasound devices
5.2.4 CHALLENGES
5.2.4.1 Growing end-user preference for refurbished equipment
5.2.4.2 Shortage of skilled sonographers
5.3 INDUSTRY TRENDS
5.3.1 ENDOSCOPIC ULTRASOUND
5.3.2 WIRELESS AND PORTABLE SYSTEMS
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 KEY STAKEHOLDERS & BUYING CRITERIA
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.7.2 BUYING CRITERIA
5.8 PATENT ANALYSIS
5.9 TRADE DATA ANALYSIS
5.9.1 IMPORT DATA
5.9.2 EXPORT DATA
5.10 KEY CONFERENCES & EVENTS, 2024–2025
5.11 UNMET NEEDS AND KEY PAIN POINTS
5.12 ECOSYSTEM ANALYSIS
5.13 IMPACT OF GEN AI ON ULTRASOUND MARKET
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 TECHNOLOGY ANALYSIS
5.15.1 KEY TECHNOLOGIES
5.15.1.1 Contrast-enhanced ultrasound (CEUS)
5.15.1.2 Portable and handheld ultrasound devices
5.15.2 COMPLEMENTARY TECHNOLOGIES
5.15.2.1 Elastography
5.15.2.2 Fluoroscopy
5.15.3 ADJACENT TECHNOLOGIES
5.15.3.1 PET/CT
5.16 CASE STUDY ANALYSIS
5.16.1 LARGE-DIAMETER LUMEN-APPOSING METAL STENTS FOR WALLED-OFF NECROSIS
5.16.2 PRENATAL DIAGNOSIS OF HYPOPHOSPHATASIA CONGENITAL USING ULTRASONOGRAPHY
5.16.3 POSTOPERATIVE PERIRECTAL ABSCESS DRAINAGE
5.17 REGULATORY ANALYSIS
5.17.1 NORTH AMERICA
5.17.1.1 US
5.17.1.2 Canada
5.17.2 EUROPE
5.17.3 ASIA PACIFIC
5.17.3.1 Japan
5.17.3.2 China
5.17.3.3 India
5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 PRICING ANALYSIS
5.19.1 AVERAGE SELLING PRICE TREND, BY REGION
5.19.2 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER
5.20 REIMBURSEMENT SCENARIO
6 ULTRASOUND MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 DIAGNOSTIC ULTRASOUND
6.2.1 2D ULTRASOUND
6.2.1.1 Growing demand for minimally invasive surgeries to increase use of 2D ultrasound
6.2.2 3D & 4D ULTRASOUND
6.2.2.1 Improved diagnosis with 3D ultrasound technology to boost market growth
6.2.3 DOPPLER ULTRASOUND
6.2.3.1 Growing applications in cardiology and vascular to drive market growth
6.2.4 CONTRAST-ENHANCED ULTRASOUND
6.2.4.1 Enhanced diagnostic imaging with advanced ultrasound systems
to boost demand
6.3 THERAPEUTIC ULTRASOUND
6.3.1 HIGH-INTENSITY-FOCUSED ULTRASOUND
6.3.1.1 Advancing cancer treatment with HIFU to fuel growth
6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
6.3.2.1 Enhancing urolithiasis treatment with advanced ESWL techniques
and technologies to propel market
7 ULTRASOUND MARKET, BY DISPLAY
7.1 INTRODUCTION
7.2 COLOR ULTRASOUND
7.2.1 GROWING DEMAND FOR COLOR ULTRASOUND TO SUPPORT MARKET GROWTH
7.3 BLACK & WHITE ULTRASOUND
7.3.1 ENHANCED DIAGNOSTIC PRECISION WITH B/W ULTRASOUND TO DRIVE DEMAND
8 ULTRASOUND MARKET, BY PORTABILITY
8.1 INTRODUCTION
8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS
8.2.1 IMPROVED PATIENT EXPERIENCE WITH TROLLEY-BASED ULTRASOUND
SYSTEMS TO DRIVE MARKET GROWTH
8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS
8.3.1 GROWING NUMBER OF TRAUMA/EMERGENCY CASES TO FUEL MARKET GROWTH
8.4 POC ULTRASOUND DEVICES
8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND
FOR POC ULTRASOUND DEVICES
9 ULTRASOUND MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 RADIOLOGY/GENERAL IMAGING
9.2.1 GROWING NUMBER OF CHRONIC DISEASES LEADING TO INCREASED
USE OF THIS APPLICATION
9.3 CARDIOLOGY
9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASE ACROSS MAJOR HEALTHCARE MARKETS TO DRIVE GROWTH
9.4 OB/GYN
9.4.1 WIDE ADOPTION OF AI IN ULTRASOUND IN FIELD OF OB/GYN TO BOOST MARKET
9.5 UROLOGY
9.5.1 WIDE USE OF ULTRASOUND IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO DRIVE MARKET
9.6 VASCULAR
9.6.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
9.7 ORTHOPEDIC & MUSCULOSKELETAL
9.7.1 RISING PREVALENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH
9.8 PAIN MANAGEMENT
9.8.1 GROWING ADOPTION OF PORTABLE ULTRASOUND FOR PAIN MANAGEMENT TO SUPPORT GROWTH
9.9 PEDIATRIC
9.9.1 GROWING USE OF PEDIATRIC ULTRASOUND TO COMBAT NEONATAL
MORTALITY TO SPUR GROWTH
9.10 OTHER APPLICATIONS
10 ULTRASOUND MARKET, BY COMPONENT
10.1 INTRODUCTION
10.2 TRANSDUCERS/PROBES
10.2.1 CURVILINEAR/CONVEX ARRAY PROBES
10.2.1.1 Enhanced diagnosis with curvilinear and convex array ultrasound
probes to boost market
10.2.2 LINEAR ARRAY PROBES
10.2.2.1 High-resolution power with linear array ultrasound systems to drive demand
10.2.3 PHASED ARRAY PROBES
10.2.3.1 Advanced imaging capabilities to drive market growth
10.2.4 OTHER PROBES
10.3 WORKSTATIONS
10.3.1 INCREASE IN DIAGNOSTIC PROCEDURES TO PROPEL DEMAND
FOR WORKSTATIONS
10.4 OTHER COMPONENTS
11 ULTRASOUND MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
11.2.1 INCREASING PREVALENCE OF CANCER TO BOOST MARKET GROWTH
11.3 MATERNITY CENTERS
11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND SYSTEMS
FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH
11.4 AMBULATORY CENTERS
11.4.1 INCREASING NUMBER OF SURGERIES TO PROPEL MARKET GROWTH
11.5 RESEARCH & ACADEMIC INSTITUTES
11.5.1 GROWING NUMBER OF RESEARCH GRANTS TO BOOST MARKET GROWTH
11.6 OTHER END USERS
12 ULTRASOUND MARKET, BY REGION
12.1 INTRODUCTION
12.2 EUROPE
12.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.2.2 GERMANY
12.2.2.1 Growing healthcare expenditures and grants to drive market
12.2.3 FRANCE
12.2.3.1 Increasing population and rising number of centers to drive market
12.2.4 UK
12.2.4.1 Increasing prevalence of chronic diseases to contribute to market growth
12.2.5 ITALY
12.2.5.1 Increased availability of reimbursement coverage for diagnostic
procedures to drive market
12.2.6 SPAIN
12.2.6.1 Growing focus on cancer research to support market growth
12.2.7 REST OF EUROPE
12.3 NORTH AMERICA
12.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.3.2 US
12.3.2.1 Rise in cancer prevalence to drive market
12.3.3 CANADA
12.3.3.1 New product launches & conferences to drive market
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Increasing acquisitions and partnerships to drive market
12.4.3 JAPAN
12.4.3.1 Established healthcare infrastructure and research facilities
to drive market
12.4.4 INDIA
12.4.4.1 Government initiatives to drive market
12.4.5 AUSTRALIA
12.4.5.1 Growing healthcare spending and increasing investments in research
to drive market
12.4.6 SOUTH KOREA
12.4.6.1 Well-developed healthcare system and conferences to drive market
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Greater purchasing power and favorable demographic conditions
to drive market
12.5.3 MEXICO
12.5.3.1 Increased medical tourism and better government healthcare
initiatives to drive market
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 GROWING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.3 GCC COUNTRIES
12.6.3.1 Developments in investment approach to drive market
12.6.4 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET
13.3 REVENUE ANALYSIS, 2019–2023
13.4 MARKET SHARE ANALYSIS, 2023
13.4.1 RANKING OF KEY MARKET PLAYERS
13.5 COMPANY EVALUATION MATRIX: DIAGNOSTIC ULTRASOUND MARKET (KEY PLAYERS), 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Technology footprint
13.5.5.4 Display footprint
13.5.5.5 Portability footprint
13.5.5.6 Component footprint
13.5.5.7 Application footprint
13.5.5.8 End-user footprint
13.6 COMPANY EVALUATION MATRIX: THERAPEUTIC ULTRASOUND MARKET
(STARTUPS/SMES), 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 GE HEALTHCARE
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches, approvals, and upgrades
14.1.1.3.2 Deals
14.1.1.3.3 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 PHILIPS HEALTHCARE
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches & approvals
14.1.2.3.2 Deals
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 CANON MEDICAL SYSTEMS CORPORATION
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 SIEMENS HEALTHINEERS AG
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Expansions
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 FUJIFILM CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 HOLOGIC, INC.
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.6.3.2 Deals
14.1.6.3.3 Expansions
14.1.7 SAMSUNG ELECTRONICS CO., LTD.
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.7.3.3 Other developments
14.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.8.3.2 Deals
14.1.9 ESAOTE SPA
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Product launches
14.1.9.3.2 Deals
14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.10.3.2 Deals
14.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD.
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Product launches
14.1.12 KONICA MINOLTA, INC
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 CLARIUS
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Product launches
14.1.13.3.2 Deals
14.1.14 MEDGYN PRODUCTS, INC.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 PROMED TECHNOLOGY CO., LTD.
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER COMPANIES
14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
14.2.2 SHENZHEN RICSO TECHNOLOGY CO., LTD.
14.2.3 YOUKEY MEDICAL
14.2.4 SIUI
14.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING
14.2.6 BUTTERFLY NETWORK, INC.
14.2.7 ALPINION MEDICAL SYSTEMS
14.2.8 EDAN INSTRUMENTS, INC.
14.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD.
14.2.10 ECHONOUS INC.
14.2.11 MOBISANTE, INC.
14.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD.
14.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
14.2.14 SONOSCAPE MEDICAL CORP.
14.2.15 CURA HEALTHCARE
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Customer-based market estimation
2.2.1.3 Approach 3: Top-down approach
2.2.1.4 Approach 4: Primary interviews
2.3 DATA TRIANGULATION & MARKET BREAKDOWN
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ULTRASOUND MARKET OVERVIEW
4.2 ULTRASOUND MARKET, BY REGION, 2022–2030
4.3 EUROPE: ULTRASOUND MARKET, BY REGION AND END USER, 2023
4.4 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Rising patient preference for minimally invasive surgeries
5.2.1.3 Rising technological advancements in ultrasound devices
5.2.1.4 Growing public and private investments, funding, and grants
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursements
5.2.2.2 High operating costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing applications of therapeutic ultrasound
5.2.3.2 Growth in emerging markets
5.2.3.3 Development of POC ultrasound devices
5.2.4 CHALLENGES
5.2.4.1 Growing end-user preference for refurbished equipment
5.2.4.2 Shortage of skilled sonographers
5.3 INDUSTRY TRENDS
5.3.1 ENDOSCOPIC ULTRASOUND
5.3.2 WIRELESS AND PORTABLE SYSTEMS
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 KEY STAKEHOLDERS & BUYING CRITERIA
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.7.2 BUYING CRITERIA
5.8 PATENT ANALYSIS
5.9 TRADE DATA ANALYSIS
5.9.1 IMPORT DATA
5.9.2 EXPORT DATA
5.10 KEY CONFERENCES & EVENTS, 2024–2025
5.11 UNMET NEEDS AND KEY PAIN POINTS
5.12 ECOSYSTEM ANALYSIS
5.13 IMPACT OF GEN AI ON ULTRASOUND MARKET
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 TECHNOLOGY ANALYSIS
5.15.1 KEY TECHNOLOGIES
5.15.1.1 Contrast-enhanced ultrasound (CEUS)
5.15.1.2 Portable and handheld ultrasound devices
5.15.2 COMPLEMENTARY TECHNOLOGIES
5.15.2.1 Elastography
5.15.2.2 Fluoroscopy
5.15.3 ADJACENT TECHNOLOGIES
5.15.3.1 PET/CT
5.16 CASE STUDY ANALYSIS
5.16.1 LARGE-DIAMETER LUMEN-APPOSING METAL STENTS FOR WALLED-OFF NECROSIS
5.16.2 PRENATAL DIAGNOSIS OF HYPOPHOSPHATASIA CONGENITAL USING ULTRASONOGRAPHY
5.16.3 POSTOPERATIVE PERIRECTAL ABSCESS DRAINAGE
5.17 REGULATORY ANALYSIS
5.17.1 NORTH AMERICA
5.17.1.1 US
5.17.1.2 Canada
5.17.2 EUROPE
5.17.3 ASIA PACIFIC
5.17.3.1 Japan
5.17.3.2 China
5.17.3.3 India
5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 PRICING ANALYSIS
5.19.1 AVERAGE SELLING PRICE TREND, BY REGION
5.19.2 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER
5.20 REIMBURSEMENT SCENARIO
6 ULTRASOUND MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 DIAGNOSTIC ULTRASOUND
6.2.1 2D ULTRASOUND
6.2.1.1 Growing demand for minimally invasive surgeries to increase use of 2D ultrasound
6.2.2 3D & 4D ULTRASOUND
6.2.2.1 Improved diagnosis with 3D ultrasound technology to boost market growth
6.2.3 DOPPLER ULTRASOUND
6.2.3.1 Growing applications in cardiology and vascular to drive market growth
6.2.4 CONTRAST-ENHANCED ULTRASOUND
6.2.4.1 Enhanced diagnostic imaging with advanced ultrasound systems
to boost demand
6.3 THERAPEUTIC ULTRASOUND
6.3.1 HIGH-INTENSITY-FOCUSED ULTRASOUND
6.3.1.1 Advancing cancer treatment with HIFU to fuel growth
6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
6.3.2.1 Enhancing urolithiasis treatment with advanced ESWL techniques
and technologies to propel market
7 ULTRASOUND MARKET, BY DISPLAY
7.1 INTRODUCTION
7.2 COLOR ULTRASOUND
7.2.1 GROWING DEMAND FOR COLOR ULTRASOUND TO SUPPORT MARKET GROWTH
7.3 BLACK & WHITE ULTRASOUND
7.3.1 ENHANCED DIAGNOSTIC PRECISION WITH B/W ULTRASOUND TO DRIVE DEMAND
8 ULTRASOUND MARKET, BY PORTABILITY
8.1 INTRODUCTION
8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS
8.2.1 IMPROVED PATIENT EXPERIENCE WITH TROLLEY-BASED ULTRASOUND
SYSTEMS TO DRIVE MARKET GROWTH
8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS
8.3.1 GROWING NUMBER OF TRAUMA/EMERGENCY CASES TO FUEL MARKET GROWTH
8.4 POC ULTRASOUND DEVICES
8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND
FOR POC ULTRASOUND DEVICES
9 ULTRASOUND MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 RADIOLOGY/GENERAL IMAGING
9.2.1 GROWING NUMBER OF CHRONIC DISEASES LEADING TO INCREASED
USE OF THIS APPLICATION
9.3 CARDIOLOGY
9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASE ACROSS MAJOR HEALTHCARE MARKETS TO DRIVE GROWTH
9.4 OB/GYN
9.4.1 WIDE ADOPTION OF AI IN ULTRASOUND IN FIELD OF OB/GYN TO BOOST MARKET
9.5 UROLOGY
9.5.1 WIDE USE OF ULTRASOUND IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO DRIVE MARKET
9.6 VASCULAR
9.6.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
9.7 ORTHOPEDIC & MUSCULOSKELETAL
9.7.1 RISING PREVALENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH
9.8 PAIN MANAGEMENT
9.8.1 GROWING ADOPTION OF PORTABLE ULTRASOUND FOR PAIN MANAGEMENT TO SUPPORT GROWTH
9.9 PEDIATRIC
9.9.1 GROWING USE OF PEDIATRIC ULTRASOUND TO COMBAT NEONATAL
MORTALITY TO SPUR GROWTH
9.10 OTHER APPLICATIONS
10 ULTRASOUND MARKET, BY COMPONENT
10.1 INTRODUCTION
10.2 TRANSDUCERS/PROBES
10.2.1 CURVILINEAR/CONVEX ARRAY PROBES
10.2.1.1 Enhanced diagnosis with curvilinear and convex array ultrasound
probes to boost market
10.2.2 LINEAR ARRAY PROBES
10.2.2.1 High-resolution power with linear array ultrasound systems to drive demand
10.2.3 PHASED ARRAY PROBES
10.2.3.1 Advanced imaging capabilities to drive market growth
10.2.4 OTHER PROBES
10.3 WORKSTATIONS
10.3.1 INCREASE IN DIAGNOSTIC PROCEDURES TO PROPEL DEMAND
FOR WORKSTATIONS
10.4 OTHER COMPONENTS
11 ULTRASOUND MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
11.2.1 INCREASING PREVALENCE OF CANCER TO BOOST MARKET GROWTH
11.3 MATERNITY CENTERS
11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND SYSTEMS
FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH
11.4 AMBULATORY CENTERS
11.4.1 INCREASING NUMBER OF SURGERIES TO PROPEL MARKET GROWTH
11.5 RESEARCH & ACADEMIC INSTITUTES
11.5.1 GROWING NUMBER OF RESEARCH GRANTS TO BOOST MARKET GROWTH
11.6 OTHER END USERS
12 ULTRASOUND MARKET, BY REGION
12.1 INTRODUCTION
12.2 EUROPE
12.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.2.2 GERMANY
12.2.2.1 Growing healthcare expenditures and grants to drive market
12.2.3 FRANCE
12.2.3.1 Increasing population and rising number of centers to drive market
12.2.4 UK
12.2.4.1 Increasing prevalence of chronic diseases to contribute to market growth
12.2.5 ITALY
12.2.5.1 Increased availability of reimbursement coverage for diagnostic
procedures to drive market
12.2.6 SPAIN
12.2.6.1 Growing focus on cancer research to support market growth
12.2.7 REST OF EUROPE
12.3 NORTH AMERICA
12.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.3.2 US
12.3.2.1 Rise in cancer prevalence to drive market
12.3.3 CANADA
12.3.3.1 New product launches & conferences to drive market
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Increasing acquisitions and partnerships to drive market
12.4.3 JAPAN
12.4.3.1 Established healthcare infrastructure and research facilities
to drive market
12.4.4 INDIA
12.4.4.1 Government initiatives to drive market
12.4.5 AUSTRALIA
12.4.5.1 Growing healthcare spending and increasing investments in research
to drive market
12.4.6 SOUTH KOREA
12.4.6.1 Well-developed healthcare system and conferences to drive market
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Greater purchasing power and favorable demographic conditions
to drive market
12.5.3 MEXICO
12.5.3.1 Increased medical tourism and better government healthcare
initiatives to drive market
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 GROWING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.3 GCC COUNTRIES
12.6.3.1 Developments in investment approach to drive market
12.6.4 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET
13.3 REVENUE ANALYSIS, 2019–2023
13.4 MARKET SHARE ANALYSIS, 2023
13.4.1 RANKING OF KEY MARKET PLAYERS
13.5 COMPANY EVALUATION MATRIX: DIAGNOSTIC ULTRASOUND MARKET (KEY PLAYERS), 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Technology footprint
13.5.5.4 Display footprint
13.5.5.5 Portability footprint
13.5.5.6 Component footprint
13.5.5.7 Application footprint
13.5.5.8 End-user footprint
13.6 COMPANY EVALUATION MATRIX: THERAPEUTIC ULTRASOUND MARKET
(STARTUPS/SMES), 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 GE HEALTHCARE
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches, approvals, and upgrades
14.1.1.3.2 Deals
14.1.1.3.3 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 PHILIPS HEALTHCARE
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches & approvals
14.1.2.3.2 Deals
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 CANON MEDICAL SYSTEMS CORPORATION
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 SIEMENS HEALTHINEERS AG
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Expansions
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 FUJIFILM CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 HOLOGIC, INC.
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.6.3.2 Deals
14.1.6.3.3 Expansions
14.1.7 SAMSUNG ELECTRONICS CO., LTD.
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.7.3.3 Other developments
14.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.8.3.2 Deals
14.1.9 ESAOTE SPA
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Product launches
14.1.9.3.2 Deals
14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.10.3.2 Deals
14.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD.
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Product launches
14.1.12 KONICA MINOLTA, INC
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 CLARIUS
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Product launches
14.1.13.3.2 Deals
14.1.14 MEDGYN PRODUCTS, INC.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 PROMED TECHNOLOGY CO., LTD.
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER COMPANIES
14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
14.2.2 SHENZHEN RICSO TECHNOLOGY CO., LTD.
14.2.3 YOUKEY MEDICAL
14.2.4 SIUI
14.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING
14.2.6 BUTTERFLY NETWORK, INC.
14.2.7 ALPINION MEDICAL SYSTEMS
14.2.8 EDAN INSTRUMENTS, INC.
14.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD.
14.2.10 ECHONOUS INC.
14.2.11 MOBISANTE, INC.
14.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD.
14.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
14.2.14 SONOSCAPE MEDICAL CORP.
14.2.15 CURA HEALTHCARE
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
